Showing results (271-280 of 282) with videos related to
Sort By:
Pageof 29
Signal Transduction and Targeted Therapy|January 21, 2025
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cellsGui-Qi Zhu, Zheng Tang, Tian-Hao Chu, et al.Clinical Science (London, England : 1979)|November 18, 2015
Involvement of the Hippo pathway in regeneration and fibrogenesis after ischaemic acute kidney injury: YAP is the key effectorJing Xu, Pei-Xue Li, Jun Wu, et al.Nature Methods|November 1, 2018
A mutant-cell library for systematic analysis of heparan sulfate structure-function relationshipsHong Qiu, Songshan Shi, Jingwen Yue, et al.BJS Open|September 20, 2022
Conversion therapy for initially unresectable hepatocellular carcinoma using a combination of toripalimab, lenvatinib plus TACE: real-world studyWei-Feng Qu, Zhen-Bin Ding, Xu-Dong Qu, et al.Science Advances|May 2, 2025
Targeting HMGB2 acts as dual immunomodulator by bolstering CD8+ T cell function and inhibiting tumor growth in hepatocellular carcinomaWei-Feng Qu, Gui-Qi Zhu, Rui Yang, et al.Cell|January 30, 2025
Identification, structure, and agonist design of an androgen membrane receptorZhao Yang, Yu-Qi Ping, Ming-Wei Wang, et al.Hepatology International|April 8, 2023
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantationWei-Feng Qu, Meng-Xin Tian, Hong-Wei Lu, et al.Cellular Oncology (Dordrecht, Netherlands)|April 12, 2024
Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migrationChen-Yang Tao, Xiao-Ling Wu, Shu-Shu Song, et al.EMBO Reports|March 2, 2018
SIRT5 inhibits peroxisomal ACOX1 to prevent oxidative damage and is downregulated in liver cancerXiu-Fei Chen, Meng-Xin Tian, Ren-Qiang Sun, et al.Communications Biology|November 21, 2023
Single-cell and spatial architecture of primary liver cancerPei-Yun Zhou, Cheng Zhou, Wei Gan, et al.Pageof 29